1. Pharmacological effects and potential therapeutic targets of DT-13
   Ghulam Jilany Khan et al, 2018, Biomedicine & Pharmacotherapy CrossRef
2. DT-13 synergistically potentiates the sensitivity of gastric cancer cells to topotecan via cell cycle arrest in vitro and in vivo
   Hongzhi Du et al, 2018, European Journal of Pharmacology CrossRef
3. DT-13 ameliorates TNF-α-induced nitric oxide production in the endothelium in vivo and in vitro
   Ruiping Fan et al, 2017, Biochemical and Biophysical Research Communications CrossRef
4. DT-13 Ameliorates TNF-α-Induced Vascular Endothelial Hyperpermeability via Non-Muscle Myosin IIA and the Src/PI3K/Akt Signaling Pathway.
   Yuanyuan Zhang et al, 2017, Front Immunol CrossRef
5. Regulation of different components from Ophiopogon japonicus on autophagy in human lung adenocarcinoma A549Cells through PI3K/Akt/mTOR signaling pathway
   Juan Chen et al, 2017, Biomedicine & Pharmacotherapy CrossRef
6. Silibinin Inhibits NSCLC Metastasis by Targeting the EGFR/LOX Pathway
   Xiaoying Hou et al, 2018, Front. Pharmacol. CrossRef
7. DT-13 inhibited the proliferation of colorectal cancer via glycolytic metabolism and AMPK/mTOR signaling pathway
   Xiaohui Wei et al, 2018, Phytomedicine CrossRef
8. DT-13 suppresses breast cancer metastasis by modulating PLOD2 in the adipocytes microenvironment
   Jinyong He et al, 2018, Phytomedicine CrossRef
9. Adipocyte-derived IL-6 and leptin promote breast Cancer metastasis via upregulation of Lysyl Hydroxylase-2 expression
   Jin-Yong He et al, 2018, Cell Commun Signal CrossRef
10. In-vitro Pre-Treatment of Cancer Cells with TGF-β1: A Novel Approach of Tail Vein Lung Cancer Metastasis Mouse Model for Anti-Metastatic Studies.
    Ghulam Jilany Khan et al, 2019, Curr Mol Pharmacol CrossRef
11. DT-13 inhibits breast cancer cell migration via non-muscle myosin II-A regulation in tumor microenvironment synchronized adaptations
    Y. Gao et al, 2020, Clin Transl Oncol CrossRef
12. MICAL2 is a novel nucleocytoplasmic shuttling protein promoting cancer invasion and growth of lung adenocarcinoma
    Wolong Zhou et al, 2020, Cancer Letters CrossRef
13. MYH9 overexpression correlates with clinicopathological parameters and poor prognosis of epithelial ovarian cancer
    Longyang Liu et al, 2019, Oncol Lett CrossRef
14. Computational pharmacology and bioinformatics to explore the potential mechanism of Schisandra against atherosclerosis
    Hong Duan et al, 2021, Food and Chemical Toxicology CrossRef
15. Current and future biomarkers in gastric cancer
    Muhammad Abbas et al, 2018, Biomedicine & Pharmacotherapy CrossRef
16. Ophiopogon japonicus and its active compounds: A review of potential anticancer effects and underlying mechanisms
    Qiao Liu et al, 2023, Phytomedicine CrossRef
17. Effects of saponins from Chinese herbal medicines on signal transduction pathways in cancer: A review
    Mingtao Zhu et al, 2023, Front. Pharmacol. CrossRef
18. DT-13 inhibits the proliferation of pancreatic cancer by inducing apoptosis via AMPK-mTOR signaling
    Gangyin Xie et al, 2023, Biochemical and Biophysical Research Communications CrossRef
19. MYH9: A key protein involved in tumor progression and virus-related diseases
    Qing Liu et al, 2024, Biomedicine & Pharmacotherapy CrossRef
20. Non-Muscle Myosin IIC as a Prognostic and Therapeutic Target in Cancer
    Ghulam Jilany Khan et al, 2024, j biomed nanotechnol CrossRef
21. Advances in antitumor activity and mechanism of natural steroidal saponins: A review of advances, challenges, and future prospects
    Fengge Wang et al, 2024, Phytomedicine CrossRef